菲利林:通过调节NF-κB和Nrf2信号通路来治疗骨关节炎的潜在治疗剂
Jiawei Ma1, Ze Wang1, Yun Sun1
1Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325088, Zhejiang Province, China; Zhejiang Provincial Key Laboratory of Orthopedics, Wenzhou 325035, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou 325035, Zhejiang Province, China.
International immunopharmacology
|August 19, 2024
概括
菲利林 (Phillyrin) 是一种福西西亚提取物,通过减少炎症和软骨退化来治疗骨关节炎,显示出有前途. 它抑制NF-κB通路,减轻淋巴细胞的衰老,并防止疾病的进展.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
- 免疫学 免疫学 免疫学
背景情况:
- 骨关节炎 (OA) 是导致残疾的主要原因,其特点是软骨退化和骨变化.
- 包括菲利林在内的福西西提取物具有已知的抗炎和抗菌特性.
- 菲利林的特定抗骨关节炎作用和机制尚未完全理解.
研究的目的:
- 评估菲利林对IL-1β诱导的小鼠胆红细胞的抗炎和抗衰老作用.
- 阐明菲利林在骨关节炎中的作用背后的分子机制.
- 为了评估phillyrin在小鼠骨关节炎模型中的治疗潜力.
主要方法:
- 网络药理学和分子对接确定了NFE2L2 (NRF2),NFKB1,TLR4和SERPING1作为主要目标.
- 在体外研究中,研究了菲利林对IL-1β刺激的红细胞的影响.
- 在体内研究中使用了小鼠骨关节炎模型来评估phillyrin的疗效.
主要成果:
- 菲利林抑制了由IL-1β诱导的促炎因素 (TNF-α,COX-2,IL-6,iNOS) 的表达.
- 菲利林可以防止细胞外基因组件 (亚格格兰,原II) 的降解.
- 菲利林抑制了NF-κB通路,减轻了软骨细胞的衰老和炎症.
结论:
- 菲利林表现出与骨关节炎相关的显著抗炎和抗衰老特性.
- 抑制NF-κB通路是菲利林治疗效果的一个关键机制.
- 菲利林是骨关节炎治疗的潜在治疗剂.
相关概念视频
02:26NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
162
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
162
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K